# Influence of massive material injection on avalanche runaway generation during tokamak disruptions

Article · L Hesslow, O Embréus, O Vallhagen, T Fülöp

- Archive id: arxiv:1904.00602
- Published: 2019-04-01
- Venue: Nuclear Fusion 59, 084004 (2019)
- DOI: https://doi.org/10.1088/1741-4326/ab26c2
- arXiv: https://arxiv.org/abs/1904.00602
- Citations: 85
- Source URL: https://arxiv.org/abs/1904.00602
- PDF: https://arxiv.org/pdf/1904.00602
- Provenance: arxiv

## Abstract

In high-current tokamak devices such as ITER, a runaway avalanche can cause a large amplification of a seed electron population. We show that disruption mitigation by impurity injection may significantly increase the runaway avalanche growth rate in such devices. This effect originates from the increased number of target electrons available for the avalanche process in weakly ionized plasmas, which is only partially compensated by the increased friction force on fast electrons. We derive an expression for the avalanche growth rate in partially ionized plasmas and investigate the effects of impurity injection on the avalanche multiplication factor and on the final runaway current for ITER-like parameters. For impurity densities relevant for disruption mitigation, the maximum amplification of a runaway seed can be increased by tens of orders of magnitude compared to previous predictions. This motivates careful studies to determine the required densities and impurity species to obtain tolerable current quench parameters, as well as more detailed modeling of the runaway dynamics including transport effects.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Magnetic Confinement Fusion](https://space-kitty.com/topics/magnetic-fusion)

Cited in dossiers:
- [Magnetic Confinement Fusion: State of the Field (October 2026)](https://space-kitty.com/dossiers/magnetic-fusion)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.